Section for Evidence-based Medicine in Psychiatry and Psychotherapy

Prof. Dr. med. Stefan Leucht
Deputy Director, Head of the Section for Evidence-based Medicine in Psychiatry and Psychotherapy
Head: Prof. Dr. med. Stefan Leucht
Link to own homepage : https://ebmpp.org/en
Work areas
- Evidence-based medicine in psychiatry and psychotherapy
- Systematic reviews and meta-analyses
- Cochrane reviews
- Network meta-analyses
- Diagnostic test reviews
- Individual patient data meta-analyses
- Dose- Aspects of clinical trials
- Participatory decision making
- Therapy apps
- Surveys
Current projects
- Evidence on antipsychotic drug treatment for schizophrenia from Western and Chinese trials: building a comprehensive database, training investigators and applying network meta-analysis (DFG)
- Treatment of acute agitation and aggression under real-life conditions. Data from individual patients, network meta-analysis of randomized controlled trials (BMBF)
- Muscarinic agonists and positive allosteric modulators in animal models of schizophrenia:a systematic review and meta-analysis (ANIMUS, BMBF)
- Antipsychotics and their effects on cognitive function: A systematic review, pairwise meta-analysis and network meta-analysis (BMBF)
- Individual-patient data meta-analysis on the efficacy of clozapine compared with second-generation antipsychotics in patients with treatment-resistant schizophrenia (BMBF)
- Non-invasive brain stimulation in treatment-resistant schizophrenia: A systematic review and network meta-analysis (BMBF)
- Psychological interventions in the early phase of schizophrenia: a systematic review and network meta-analysis (BMBF)
- Sexual side effects of antipsychotics: A systematic review with single-arm,pairwise and network meta-analysis of randomized controlled trials and non-randomized studies (BMBF)
- Evaluation of a school project to destigmatize mental illness (German Center for Mental Health, BMBF)
- Living meta-analysis of pharmacokinetic drug-gene interactions in psychiatry: The importance of CYP450 genetic polymorphism (Humboldt Foundation)
- Use of an evidence-based decision aid on antipsychotics for hospitalized patients with schizophrenia (EVENT, Innovation Fund)
- IT-based relapse monitoring for schizophrenia (ILIA; Innovation Fund)
- Global Alliance for Living Evidence on aNxiety, depressiOn and pSychosis (GALENOS; Wellcome Trust)
Publications
https://pubmed.ncbi.nlm.nih.gov/?term=Leucht-S&sort=date
Cooperation partners (selection)
- Link to map: https://ebmpp.org/en/cooperations
- German Center for Mental Health
- World Health Organization
- Cochrane Schizophrenia Group
- University of Oxford
- University of Illinois at Chicago
- Kyoto University
- Hoofstra University New York
- Shanghai Mental Health Center
- University of Haifa